Axonics, Inc. (AXNX)
Company Info
ISIN | US05465P1012 |
---|---|
CUSIP | 05465P101 |
Sector | Healthcare |
Industry | Medical Devices |
Highlights
Market Cap | $3.48B |
---|---|
EPS | -$0.12 |
Revenue (TTM) | $366.38M |
Gross Profit (TTM) | $197.67M |
EBITDA (TTM) | $7.78M |
Year Range | $47.59 - $69.68 |
Target Price | $71.73 |
Short % | 6.24% |
Short Ratio | 3.23 |
Share Price Chart
Loading data...
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Axonics, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Axonics, Inc. had a return of 10.83% year-to-date (YTD) and 23.14% in the last 12 months.
Period | Return | Benchmark |
---|---|---|
Year-To-Date | 10.83% | 10.16% |
1 month | 0.97% | 3.47% |
6 months | 21.00% | 22.20% |
1 year | 23.14% | 30.45% |
5 years (annualized) | 23.60% | 13.16% |
10 years (annualized) | N/A | 10.89% |
Monthly Returns Heatmap
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | 9.08% | 0.09% | ||||||||||
2023 | -5.09% | -2.06% | -8.75% | 9.33% | 11.14% |
Risk-Adjusted Performance
Risk-Adjusted Performance Indicators
This table presents risk-adjusted performance metrics for Axonics, Inc. (AXNX) and compares them with a selected benchmark (^GSPC). These performance indicators assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Ulcer Index | |
---|---|---|---|---|---|
Axonics, Inc. | 0.59 | ||||
S&P 500 | 2.79 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Axonics, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Axonics, Inc. was 61.24%, occurring on Mar 18, 2020. Recovery took 92 trading sessions.
The current Axonics, Inc. drawdown is 12.32%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
---|---|---|---|---|---|---|
-61.24% | Jul 2, 2019 | 180 | Mar 18, 2020 | 92 | Jul 29, 2020 | 272 |
-49.78% | Sep 8, 2021 | 169 | May 9, 2022 | — | — | — |
-23.86% | Mar 22, 2019 | 19 | Apr 17, 2019 | 15 | May 9, 2019 | 34 |
-20.57% | Aug 6, 2020 | 23 | Sep 8, 2020 | 13 | Sep 25, 2020 | 36 |
-18.93% | Dec 13, 2018 | 17 | Jan 8, 2019 | 27 | Feb 15, 2019 | 44 |
Volatility
Volatility Chart
The current Axonics, Inc. volatility is 1.79%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
TTM | |
---|---|
Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |